CA2782631A1 - Traitement de maladies infectieuses - Google Patents

Traitement de maladies infectieuses Download PDF

Info

Publication number
CA2782631A1
CA2782631A1 CA2782631A CA2782631A CA2782631A1 CA 2782631 A1 CA2782631 A1 CA 2782631A1 CA 2782631 A CA2782631 A CA 2782631A CA 2782631 A CA2782631 A CA 2782631A CA 2782631 A1 CA2782631 A1 CA 2782631A1
Authority
CA
Canada
Prior art keywords
alkyl
tonabersat
analogue
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2782631A
Other languages
English (en)
Inventor
Peter Blower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Publication of CA2782631A1 publication Critical patent/CA2782631A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2782631A 2009-12-03 2010-12-03 Traitement de maladies infectieuses Abandoned CA2782631A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26623409P 2009-12-03 2009-12-03
US61/226,234 2009-12-03
PCT/GB2010/052020 WO2011067607A1 (fr) 2009-12-03 2010-12-03 Traitement de maladies infectieuses

Publications (1)

Publication Number Publication Date
CA2782631A1 true CA2782631A1 (fr) 2011-06-09

Family

ID=44115623

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2782631A Abandoned CA2782631A1 (fr) 2009-12-03 2010-12-03 Traitement de maladies infectieuses

Country Status (7)

Country Link
EP (1) EP2506847A1 (fr)
CN (1) CN102770134A (fr)
AU (1) AU2010325755A1 (fr)
CA (1) CA2782631A1 (fr)
MX (1) MX2012006353A (fr)
RU (1) RU2012124838A (fr)
WO (1) WO2011067607A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140011773A1 (en) 2012-07-03 2014-01-09 Proximagen Limited Pro-drug Compounds
EP3685832B1 (fr) 2014-09-19 2023-08-30 Memorial Sloan-Kettering Cancer Center Procédés pour le traitement de métastases cérébrales
JP6720301B2 (ja) 2015-07-15 2020-07-08 テラネクス 脳のヘミチャネルを遮断するためのアミトリプチリンの使用及びその効果をｉｎ ｖｉｖｏで増強する方法
US20220401408A1 (en) * 2019-09-13 2022-12-22 Auckland Uniservices Limited Compositions and methods for rescuing retinal and choroidal structure and function

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100305149B1 (ko) 1992-12-11 2001-11-22 피터 기딩스 이환식화합물을함유한제약조성물
JP3575767B2 (ja) 1994-06-10 2004-10-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ベンゾピランおよび治療剤としてのそれらの使用
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
US20090092624A1 (en) * 2007-08-17 2009-04-09 Alberte Randall S Antiinfective Flavononol Compounds and Methods of Use Thereof

Also Published As

Publication number Publication date
CN102770134A (zh) 2012-11-07
MX2012006353A (es) 2012-06-27
RU2012124838A (ru) 2014-01-10
WO2011067607A1 (fr) 2011-06-09
AU2010325755A1 (en) 2012-06-21
EP2506847A1 (fr) 2012-10-10

Similar Documents

Publication Publication Date Title
JP2019530751A (ja) 神経変性疾患を処置するためのカンナビノイド含有複合混合物
US20080255224A1 (en) Pharmacological treatment of psoriasis
US20080020048A1 (en) Treatment of Respiratory Disease
CA2341035A1 (fr) Administration pulmonaire de cannabinoides encapsules dans des liposomes
WO2007140786A1 (fr) Utilisation de médicaments qui induisent une hypothermie
CA2726878A1 (fr) Nouveaux traitements
CA2782631A1 (fr) Traitement de maladies infectieuses
US20110319482A1 (en) Novel treatments
EP2608847B1 (fr) Théobromine combinée à un expectorant ou à un mucolytique et son utilisation en thérapie
WO2009124553A2 (fr) Utilisation de médicaments induisant une hypothermie
US20120309822A1 (en) Treatment of infectious diseases
BRPI0616144A2 (pt) composiÇço terapÊutica, uso de uma composiÇço terapÊutica,composiÇço farmacÊutica, e, uma primeira composiÇço terapÊutica compreendendo um composto s-nitrosotiol e uma segunda composiÇço terapÊutica compreendendo um segundo composto que nço o composto s-nitrosotiol
CA2782625A1 (fr) Traitement de l'allodynie et de l'hyperalgesie
CA2901208A1 (fr) Agents analgesiques oculaires topiques
JP2013512887A (ja) 感染症の治療
NL2022614B1 (en) Pharmaceutical, phyto-cannabinoid based compositions
JP2013014568A (ja) 単純ヘルペスウイルスを処置するための組成物および方法
KR20050094810A (ko) 로플루미래스트와 ｒ,ｒ-포르모테롤을 포함하는 상승작용성조합물
JP2013512888A (ja) 異痛および痛覚過敏の治療
WO2008106738A1 (fr) Compositions pour le traitement des dysfonctionnements sexuels
KR20010014366A (ko) 엘레트립탄 헤미술페이트 및 카페인을 포함하는 약제학적조성물

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20141203